Jahn SW, Bosl A, Tsybrovskyy O, Gruber-Rossipal C, et al. Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests. Br J Cancer 2020 Apr 27. pii: 10.1038/s41416-020-0838.
PMID: 32336753